Login

Let's Talk About Your Organization's Retirement Plan | Rene Bruner - Advisor of smith bruer advisors 00:10:00

Share On Facebook Share On Twitter

Rene Bruner is the CFP and Advisor of smith bruer advisors

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Telkom's profit more than halved due to declines in fixed, mobile, and IT services revenue in its latest six-month results.
00:10:00
From Sherburne to Cazenovia: A Journey Through Childhood, Education, and Family Life
00:10:00
Weekly Market Report: March 12, 2018 | Thomas J. Saunders, Managing Director, Winthrop Partners.
00:10:00
Meriva Capital Markets to Sponsor the 4th International Dollar Markets Forum in Panama
00:10:00
Intrepid Metals Corp CEO Ken Brophy discusses the company's move to OTCQB, progress on the Corral Copper project, and ambitious plans for exploration and expansion in Arizona's mining-rich regions.|Ken Brophy CEO of Intrepid Metals Corp.
00:10:00
Innovating Real Estate: JLL's Approach to Technology, Transparency, and Geopolitical Challenges | Christian Ulbrich, CEO, JLL.
00:10:00
Seeing Machines’ technology powers products that need to deliver reliable real-time understanding of vehicle operators|Paul McGlone,CEO,Seeing Machines Ltd
00:10:00
Chris Lee on Job Growth from Ports America's Investment in the Port of Oakland
00:10:00
AdvisorHub CEO Tony Sirianni interviews Jeff Stewart, Managing Director at Hilltop Securities, in a Zoom call about industry insights.
00:10:00
Investing in the first institutional round of investment for software and hardware companies|Charles Hudson,Managing Partner,Precursor Ventures
00:00:00
Facial Paralysis: Is Surgery Necessary - Samir Mardini, M.D. Facial Plastic Surgeon, Mayo clinic
00:00:00
e-Therapeutics PLC using its drug discovery platform - Jonny Wray, CTO, E-Therapeutics PLC

© 2017 - Neuhu+